• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Novel strategy targeting myeloid cells-mediated invasion of oral cancer

Research Project

Project/Area Number 18K09741
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 57060:Surgical dentistry-related
Research InstitutionUniversity of Toyama

Principal Investigator

Noguchi Makoto  富山大学, 学術研究部医学系, 教授 (50208328)

Co-Investigator(Kenkyū-buntansha) 山崎 学  新潟大学, 医歯学系, 助教 (10547516)
笹原 正清  富山大学, 学術研究部医学系, 教授 (20154015)
藤原 久美子  富山大学, 学術研究部医学系, 助教 (60404737)
冨原 圭  富山大学, 学術研究部医学系, 准教授 (70404738)
Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords口腔癌 / 局所浸潤過程 / 癌関連線維芽細胞 / 破骨細胞分化 / 免疫抑制性細胞 / 局所浸潤 / 骨髄由来免疫抑制性細胞 / 免疫抑制 / 顎骨浸潤 / 破骨細胞 / 免疫 / マウスモデル
Outline of Final Research Achievements

In this study, we aimed to establish novel strategy to target myeloid derived suppressor cell (MDSC)-mediated invasion of oral cancer. Osteoclast differentiation is crucial for bone invasion of oral cancer and one of the cell surface marker for osteoclast is CD11b which is also the marker of MDSC. Therefore, the similarity of osteoclast and MDSC have been suggested. Moreover, the cancer-associated fibroblasts are also important for tumor invasion in various cell types of cancer. We observed that PDGFR-alpha positive cells were accumulated in oral cancer-bearing mice and these cells also expressed CD11b and Gr-1, suggesting that association between CAF and MDSC. Moreover, we purified these CD11b+, Gr-1+ cells from spleen, peripheral blood, and tumor tissue, and evaluated the capacity for osteoclast differentiation. CD11b+, Gr-1+ cells from tumor tissue exhibited significantly increased capacity for osteoclast differentiation compared to those from other sites.

Academic Significance and Societal Importance of the Research Achievements

口腔扁平上皮癌の顎骨浸潤を誘導する破骨細胞も、MDSC同様にCD11b陽性の骨髄系由来の細胞である。また、腫瘍の浸潤には、腫瘍組織内の線維芽細胞である、いわゆる癌関連線維芽細胞cancer associated fibroblast(以下CAF)が重要な役割を果たすことも示唆されている。腫瘍浸潤過程におけるMDSCの果たす役割を解明することを目的とした本研究は、極めて新規性の高い研究と考えられる。以上、本研究により、口腔扁平上皮癌の浸潤局所における免疫応答からみたCAF発生、破骨細胞分化機序の一端が解明されれば、これを標的とした標的化治療の開発に繋がることが期待される。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (6 results)

All 2019

All Presentation (6 results) (of which Invited: 1 results)

  • [Presentation] A new trend in cancer therapy: Immunotherapy for advancer oral cancer2019

    • Author(s)
      Noguchi M
    • Organizer
      2nd International Conference on Biophysical Technology in Dentistry(ICoBTD2019)
    • Related Report
      2019 Research-status Report
    • Invited
  • [Presentation] 口腔扁平上皮癌における骨髄由来免疫抑制細胞(MDSC)の破骨細胞分化との関連2019

    • Author(s)
      石戸克尚,冨原 圭,平識 亘,櫻井航太郎,野口 誠
    • Organizer
      第73回日本口腔科学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] 腫瘍に集積するミエロイド系細胞の違いはPD-L1阻害剤との併用免疫療法効果に影響を与える2019

    • Author(s)
      立浪秀剛,西井 直人,加島 義久,冨原 圭,野口 誠,東 みゆき
    • Organizer
      第73回日本口腔科学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] Neutrophil-to-lymphocyte ratio as a predictable biomarker for response to nivolumab in oral squamous cell carcinoma2019

    • Author(s)
      Tachinami H, Tomihara K, Noguchi M
    • Organizer
      The 78th J Annual Meeting of the Japanese Cancer Association
    • Related Report
      2019 Research-status Report
  • [Presentation] 老齢口腔癌マウスを用いた免疫細胞および抗腫瘍免疫応答に関する研究2019

    • Author(s)
      石戸克尚,立浪秀剛,櫻井航太郎,平識 亘,冨原 圭,野口 誠
    • Organizer
      第64回日本口腔外科学会総会・学術大会
    • Related Report
      2019 Research-status Report
  • [Presentation] 口腔癌におけるnivolumab投与による 好中球数/リンパ球数比の変化2019

    • Author(s)
      立浪秀剛,冨原 圭,石戸克尚,池田篤司,藤原久美子,野口 誠
    • Organizer
      第64回日本口腔外科学会総会・学術大会
    • Related Report
      2019 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi